View in EDS

Perfluorooctanesulfonic acid (PFOS) administration shifts the hepatic proteome and augments dietary outcomes related to hepatic steatosis in mice.

Saved in:
Bibliographic Details
Title: Perfluorooctanesulfonic acid (PFOS) administration shifts the hepatic proteome and augments dietary outcomes related to hepatic steatosis in mice.
Authors: Marques, Emily1 (AUTHOR), Pfohl, Marisa1 (AUTHOR), Auclair, Adam1 (AUTHOR), Jamwal, Rohitash1 (AUTHOR), Barlock, Benjamin J.1 (AUTHOR), Sammoura, Ferass M.1 (AUTHOR), Goedken, Michael2 (AUTHOR), Akhlaghi, Fatemeh1 (AUTHOR), Slitt, Angela L.1 (AUTHOR) aslitt@uri.edu
Source: Toxicology & Applied Pharmacology. Dec2020, Vol. 408, pN.PAG-N.PAG. 1p.
Database: Environment Complete
Description
ISSN:0041008X
DOI:10.1016/j.taap.2020.115250